Rizatriptan Benzoate
Product Images NDC 50090-3921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 50090-3921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500903921)

FDA Label Image

Chemical Structure (Rizatriptan 01)

Chemical Structure (Rizatriptan 01)
COOH refers to the carboxyl functional group consisting of a carbon atom double-bonded to an oxygen atom and single-bonded to a hydroxyl group (-OH). It is commonly found in organic compounds such as amino acids, fatty acids, and acetic acid.*
FDA Label Image

Figure 1 (Rizatriptan 02)

Figure 1 (Rizatriptan 02)
This is a graph that shows an estimated probability of response for Rizatriptan benzoate tablets. The graph presents different percentages based on the hours post-dose and the dosage. There are different possibilities of response, from 0% to 100%, with a curve showing the highest probability of response around 2 hours post-dose.*
FDA Label Image

Figure 2 (Rizatriptan 03)

Figure 2 (Rizatriptan 03)
This appears to be a graph or chart representing the estimated probability of remedication or rescue after taking different dosages of Rizatriptan Benzoate Tablets. The x-axis shows hours post-dose and the y-axis shows the estimated probability percentage. The two dosages shown are 5 mg and 10 mg. However, the text is incomplete and not entirely clear, so more information cannot be accurately determined.*
FDA Label Image

Figure 5 (Rizatriptan 04)

Figure 5 (Rizatriptan 04)
The text seems to be a chart or graph showing the percent (95% CI) of Rizatriptan Benzoate Orally Disintegrating Tablets compared to a placebo at different hours post stage 2 dose. Without more context or information, it is difficult to provide a more detailed description.*
FDA Label Image

Image (Rizatriptan 05)

Image (Rizatriptan 05)
This text provides instructions on how to open a blister pack by pulling apart one of the blisters along the dotted lines until it is fully separated.*
FDA Label Image

Image (Rizatriptan 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.